The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 82.
232. lappuse
... compound claimed have a property somewhat different from correspond- ing dyes produced from the reference compound seems to me to be wholly irrelevant to the question . The statute refers to the ' subject matter sought to be patented ...
... compound claimed have a property somewhat different from correspond- ing dyes produced from the reference compound seems to me to be wholly irrelevant to the question . The statute refers to the ' subject matter sought to be patented ...
241. lappuse
... compound claims were sought , as well as process and composition claims that were generic and species in form with respect to the compound . The prior art included the trichloro analog to the dichloro compound specifically claimed ...
... compound claims were sought , as well as process and composition claims that were generic and species in form with respect to the compound . The prior art included the trichloro analog to the dichloro compound specifically claimed ...
277. lappuse
... compound unless you have tested it , In re Nelson notwithstanding . This is a compound which is sup- posed to have some utility as an end product , and none could be found . What happens to this compound now ? The inventor has given up ...
... compound unless you have tested it , In re Nelson notwithstanding . This is a compound which is sup- posed to have some utility as an end product , and none could be found . What happens to this compound now ? The inventor has given up ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention